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Unbalanced group-level models are common in neuroimaging. Typically, data for these
models come from factorial experiments. As such, analyses typically take the form of
an analysis of variance (ANOVA) within the framework of the general linear model (GLM).
Although ANOVA theory is well established for the balanced case, in unbalanced designs
there are multiple ways of decomposing the sums-of-squares of the data. This leads to
several methods of forming test statistics when the model contains multiple factors and
interactions. Although the Type I–III sums of squares have a long history of debate in
the statistical literature, there has seemingly been no consideration of this aspect of the
GLM in neuroimaging. In this paper we present an exposition of these different forms
of hypotheses for the neuroimaging researcher, discussing their derivation as estimable
functions of ANOVA models, and discussing the relative merits of each. Finally, we
demonstrate how the different hypothesis tests can be implemented using contrasts
in analysis software, presenting examples in SPM and FSL.
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1. INTRODUCTION
The general linear model (GLM) is a ubiquitous tool in neuroimaging, forming the basis of most
common analysis approaches. Users of neuroimaging software packages are well placed to harness
the power of the GLM given that tools such as FSL and SPM provide great flexibility in the forms
of models that can be specified and the hypotheses that can be tested. Whilst largely advantageous,
one drawback is that such flexibility demands the user understand in detail the underlying theory
of the GLM. A part of this understanding is the concept of estimable functions in linear models,
particularly in the case of unbalanced data. This is none more relevant than for the different
forms of hypotheses that can be tested in unbalanced group-level ANOVA designs containing
interactions. In the statistical literature there is a long history of debate around the relative
merits of the Type I–III sums of squares. Despite this, there has seemingly been no discussion
or clarity on the use of these different forms of hypothesis tests in neuroimaging. In addition, there
exists no clear guidance on how such hypothesis tests could be implemented in popular software
packages.
In this paper we present a guide for the neuroimaging researcher on the different forms of
estimable functions that are possible in the case of unbalanced ANOVA models of neuroimaging
data.We also present debate and opinion on the relativemerits of each, emphasizing the hypotheses
tested by each type in relation to the cell means of the design. To this end we begin with a review of
the theory behind balancedANOVAmodels in theGLM. This paves the way for themain discussion
of unbalanced ANOVA designs, turning to the derivation of the different forms of sums of squares
and their implementation using contrasts in neuroimaging software.
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2. THE BALANCED OVERPARAMETERIZED
ANOVA MODEL IN THE GLM
The univariate GLM can be expressed as
Y = Xθ + ǫ
where Y is the n × 1 vector of observed values, X is the n × k
design matrix, θ is the k × 1 vector of parameters, and ǫ is the
n× 1 vector of errors. Solving for θ is usually achieved using the
ordinary least-squares (OLS) estimator,
θˆ = (X′X)−1X′Y (1)
assuming that X′X is invertible. These quantities are guaranteed
the best linear unbiased estimates (BLUEs) under the conditions
of the Gauss-Markov theorem (Christensen, 2011). Although this
theorem does not require specification of a distribution for the
data, such assumptions allow for the construction of hypothesis
tests. It is therefore usual to assume that the data are drawn from
a multivariate normal distribution, denoted Y ∼ N (Xθ, σ 2I),
which is more usefully expressed in terms of the errors as
ǫ ∼ N (0, σ 2I)
Estimation of the single variance term proceeds from the model
residuals
σˆ 2 =
1
n− r
ǫˆ
′
ǫˆ
where r = rank(X) and
ǫˆ = Y− Xθˆ
Taken together these results provide the basis for almost all
the models typically used for neuroimaging data. Although
this framework encompasses both subject-level and group-level
neuroimaging models, here we focus solely on the group-level,
specifically considering approaches such as the summary-statistic
method for group-level modeling of neuroimaging data.
2.1. The 1-Way ANOVA
In the 1-way case there is a single factor variable with i levels.
Letting Yij indicate the measurement from the ith level for the jth
subject (i = 1 . . .m, j = 1 . . . ni) the typical overparameterized
1-way model is
Yij = µ+ αi + ǫij (2)
where µ is the grand mean and αi is the effect of group i. Here,
effect denotes the difference between the grand mean and the
mean of the group. As such, the cell mean for the ith group is
given by
µi = µ+ αi
This model is overparameterized because there are more
parameters than cell means. In other words, if i = 1, 2, 3 then
there are three unique model equations
µ1 = µ+ α1
µ2 = µ+ α2
µ3 = µ+ α3
with four unknowns (µ, α1, α2, α3). The consequence of this is
that there are no unique solutions for the parameter values. As
exemplified by Mumford et al. (2015), this is like trying to find 2
numbers that sum to 10. The choices are infinite.
Moving from the classical formulation of the ANOVA to its
implementation within the GLM involves reconceptualizing the
model in Equation (2) as a more generic regression model of the
form
Yij = β0x0 + β1x1 + . . . βixi + ǫij
where β0 = µ and βi = αi. The xi predictors are typically
indicator variables coding a 1 for group membership and a 0
otherwise. The x0 variable associated with the intercept is a 1 for
all observations. An observation from group 1 would therefore
render x1 = 1, with all other xi set to 0. The model then
simplifies to
Yij = β0 + β1 + ǫij
= µ+ α1 + ǫij
returning us to the classical formulation of the ANOVA. In the
GLM, the use of ANOVAmodels is therefore typified by a design
matrix containing only indicator variables of ones and zeroes. If
i = 1, 2, 3 the overparameterized 1-way ANOVA model can be
expressed in the GLM as


Y11
...
Y1n1
Y21
...
Y2n2
Y31
...
Y3n3


=


1 1 0 0
...
...
...
...
1 1 0 0
1 0 1 0
...
...
...
...
1 0 1 0
1 0 0 1
...
...
...
...
1 0 0 1




µ
α1
α2
α3

+


ǫ11
...
ǫ1n1
ǫ21
...
ǫ2n2
ǫ31
...
ǫ3n3


Here the inability to solve for the parameters can be
demonstrated by considering that X is rank deficient so that
(X′X)−1, from Equation (1), does not have a unique solution.
This can be easily seen by considering that the constant is the
sum of the other columns. As such, we have a situation of perfect
multicollinearity.
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2.2. The 2-Way ANOVA
Although the 1-way ANOVA is the most basic and instructive
case, it is only when considering models with interaction terms
that many of the issues with unbalanced data become apparent.
In the 2-way case there are two factors (denoted A and B). In
a traditional crossover design the data are sampled from the
intersection of the levels of the factors. The additive influences
of the factors are termed the main effects, with the non-additive
influence of the factors termed the interactions. These interaction
effects can be expressed as γij = µij − (µ + αi + βj), where
µij is the cell mean for level i of factor A and level j of factor
B. Expressed in this form, it is clear that the interaction effect is
simply the difference between the actual cell mean value and the
expected cell mean value if the model were purely additive.
For subject k at the ith level of A and jth level of B the 2-way
model equation is
Yijk = µ+ αi + βj + γij + ǫijk
whereµ is the grand mean, αi is the effect of the ith level of factor
A, βj is the effect of the jth level of factor B, γij is the interaction
effect, and ǫijk is the error. As with the 1-way case, this model is
overparameterized.
2.3. Estimable Functions
As indicated earlier, the problem with overparameterized models
is that there are no unique solutions for the parameter values. As
an example, consider the 2-way model given in Equation (3).


7
4
3
2
5
8
8
9


=


1 1 0 1 0 1 0 0 0
1 1 0 1 0 1 0 0 0
1 1 0 0 1 0 1 0 0
1 1 0 0 1 0 1 0 0
1 0 1 1 0 0 0 1 0
1 0 1 1 0 0 0 1 0
1 0 1 0 1 0 0 0 1
1 0 1 0 1 0 0 0 1




µ
α1
α2
β1
β2
γ11
γ12
γ21
γ22


+


ǫ111
ǫ112
ǫ121
ǫ122
ǫ211
ǫ212
ǫ221
ǫ222


(3)
Four vectors of possible solutions for these parameters are
given in Table 1. These solutions are, from left to right:
solving Equation (1) using a pseudo-inverse of X′X, re-
expressing the model using “treatment” coding, re-expressing
the model using “sigma-restricted” coding and re-expressing
the model using “cell-means” coding (see the Supplementary
Materials). Although the existence of alternatives that renderX′X
invertible may suggest that the overparameterized formulation
is overly complex and unnecessary, it is important to realize
that non-overparameterized formulations (such as the coding
schemes typically used for factors in explicit regression
models) often lead to parameters that are more difficult
to interpret. Such approaches are in fact equivalent to the
overparameterized formulation with appropriate restrictions
placed on the parameter values. As such we consider the
overparameterized model as the most generic and didactically
useful formulation of the ANOVA, despite its mathematical
intractability.
TABLE 1 | Four possible vectors of solutions for the overparameterized
2-way ANOVA model.
Parameter θˆ1 θˆ2 θˆ3 θˆ4
µ 2.556 8.5 5.75 0
α1 0.111 −6 −1.75 0
α2 2.444 0 1.75 0
β1 1.444 −2 0.25 0
β2 1.111 0 −0.25 0
γ1 1.389 5 1.25 5.5
γ2 −2.778 0 −1.25 2.5
γ3 0.056 0 −1.25 6.5
γ4 2.389 0 1.25 8.5
Returning to the values in Table 1, it is notable that although
they are all quite different they are all valid solutions as they all
lead to the same fitted values
Xθˆ1 = Xθˆ2 = Xθˆ3 = Xθˆ4 =


5.5
5.5
2.5
2.5
6.5
6.5
8.5
8.5


Because there are multiple solutions that lead to the same
estimated values, one may wonder what the worth is of any
of the individual estimates given in Table 1? In truth, these
values tell us nothing because they are dependent on the solution
chosen. There are, however, certain linear combinations of the
parameters that provide the same result irrespective of the
solution. These linear combinations are known as estimable
functions1.
An example of an estimable function for the 2-way model is,
L =
[
0 1 −1 0 0 0.5 0.5 −0.5 −0.5
]
(4)
as multiplying this vector by any one of the vectors of estimates
in Table 1 produces the same result.
Lθˆ1 = Lθˆ2 = Lθˆ3 = Lθˆ4 = −3.5
An example of a non-estimable function would be,
L∗ =
[
0 1 −1 0 0 0 0 0 0
]
1There is an element of subtlety here. The different parameter values given in
Table 1 are not necessarily “meaningless,” rather their meaning changes depending
on the solution chosen. As such, linear combinations that are not estimable can be
thought of as posing a question that depends on the coding used in the design
matrix. Their status as non-estimable simply refers to the fact that they cannot be
universally applied to answer the same question. As such, these combinations are
legitimate, so long as the parameter restrictions and coding are understood such
that the question being posed is clear.
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as multiplying this vector by the different solutions in Table 1
produces different results.
L∗θˆ1 = −2.3
L∗θˆ2 = −6
L∗θˆ3 = −3.5
L∗θˆ4 = 0
As such, the result depends on the method of solving for θ .
This is problematic, as all methods of finding solutions for the
parameters rely on some form of constraint. As argued by Nelder
(1994), such constraints should not be considered an intrinsic
part of the model as our conclusions should not depend on the
constraint. In the case of the GLM, only estimable functions can
guarantee this.
More generally, any linear combination of the parameters
coded in L is estimable if
L = TX
for some matrix T (McCulloch et al., 2008; Christensen, 2011).
In words, this result indicates that any linear combination of
the rows of X produces an estimable function due to the fact
that the rows of X are estimable functions themselves. This is
not surprising given that they dictate the predicted values of the
model via E(Y) = Xθ . However, stating this explicitly leads to a
particularly useful result, as any L is guaranteed estimable if it is
constructed using a linear combination of the rows of X.
2.4. Some Remarks on the Different
Solutions to the ANOVA Model
Throughout our examples, the scheme used to solve for
parameters in overparameterized models is the pseudo-inverse
of X′X. However, it should be recognized that alternative
approaches exist. Indeed, the three other solutions given in
Table 1 are derived from re-specifying X such that X′X is
invertible. For neuroimaging, knowledge of these alternative
approaches is particularly useful. In SPM it is usual to
specify ANOVA designs using an X of full column rank, with
overparameterized designs only occurring through the use of the
Flexible Factorial module. In FSL, group-level models
using FEAT do not allow a rank-deficient X. It is therefore
necessary for the user to directly specify the structure of X, such
that X′X can be inverted. Three common alternative approaches
are discussed in the Supplementary Materials.
The use of different coding schemes provides a direct
relationship between the presented ANOVA formulation and
modern approaches that use an explicit regression formulation
(such as linear and generalized linear mixed effects models).
In these approaches, the coding of factors is done using a
non-overparameterized scheme, and inference on the individual
parameter estimates is often performed. A number of choices
exist for the coding used, and each one has an impact on how
the parameters, and the subsequent tests on the parameters, are
interpreted. Here, a direct link with estimable functions can
be made, as the tests on individual parameter estimates in a
regression formulation is akin to the use of a single row of the
identity matrix Ik as an L. For example, in a 2 × 2 treatment
coded model, the contrast L = [ 0 1 0 0 ] cannot be formed
from an estimable function of the overparameterized model. It is,
however, equivalent to testing the single parameter coding factor
A in an explicit regression using the same coding scheme. As the
contrast is not estimable, care must be taken in interpreting the
result of any test using it. Within an explicit regression model
that contains a 2 × 2 factorial design, such a test on the single
parameter for factor A does not actually produce the equivalent
ANOVAmain effect test, instead producing somethingmore akin
to a simple effect. As will be demonstrated later, one possible
test to get the ANOVA main effect from a treatment coded
design is L = [ 0 1 0 0.5 ], which involves a linear combination
of parameters, rather than a single test on an estimated value.
Though this is clear from the ANOVA perspective, it is not always
clear in explicit regression formulations that the coding used
directly impacts the questions that are asked by the tests on the
individual parameter estimates.
2.5. Hypothesis Testing in ANOVA Models
Although solving for parameters is one important aspect of
ANOVA models, issues with unbalanced data are most readily
seen in terms of performing hypothesis tests. Traditionally, the
ANOVA hypothesis testing scheme is presented as a partitioning
of the total sums of squares of the data into independent chunks.
For a typical 2-way model, this partitioning can be expressed
algebraically as
∑
i
∑
j
∑
k(Yijk − Y¯...)
2 =
∑
i
∑
j
∑
k(Y¯i.. − Y¯...)
2
+
∑
i
∑
j
∑
k(Y¯.j. − Y¯...)
2
+
∑
i
∑
j
∑
k(Y¯ij. − Y¯i.. − Y¯.j. (5)
+ Y¯...)
2 +
∑
i
∑
j
∑
k(Yijk − Y¯ij.)
2
where Y¯ denotes a mean, and the dot notation indicates
subscripts averaged over. The partitions on the right hand side of
this expression are therefore those associated with factor A, factor
B, the A× B interaction, and the error respectively (Searle, 1987).
Dividing these quantities by their associated degrees of freedom
producesmean squares, which are used to construct the ANOVA
F tests.
The GLM hypothesis testing scheme used in neuroimaging
software revolves around a slightly more general approach. Here,
a sum-of-squares Q is constructed using,
Q = (Lθˆ)′(L(X′X)−1L′)−1(Lθˆ)
for a suitable hypothesis coded as an estimable function in L. No
matter the coding used forX, the sums of squares in Equation (5)
can all be constructed using suitable linear combinations of the
estimated model parameters in θ . The only exception is the error
sums of squares, which is constructed from the residuals. An F
test can then be performed using
F =
Q
rσˆ 2
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where r is the degrees of freedom for the hypothesis (the rank of
L), and σˆ 2 is the estimated residual variance of the model (the
mean square error).
Within this more general testing framework, the hypothesis
in question is coded in L. As such, understanding the question
being put to the data involves interrogation the structure of L.
As we will demonstrate, it is the form of L that dictates the
different approaches used for unbalanced data. When using an
overparameterized approach, however, it is often most useful to
express the hypothesis in L in relation to the cell means, rather
than in relation to the parameters. Taking an example of the L
given in Equation (4), the hypothesis test given by Lθ can be
written as
H0 : α1 − α2 +
1
2
(γ11 + γ12)−
1
2
(γ21 + γ22) = 0 (6)
Replacing the interaction terms with their expanded form, the
expression in Equation (6) can be simplified to
H0 :
1
2
(µ11 + µ12)−
1
2
(µ21 + µ22) = 0 (7)
This hypothesis therefore equates to the average of the cell means
for the first level of factor A, minus the average of the cell means
for the second level of factor A. Although somewhat trivial for
this example, this process will prove invaluable for understanding
more complex estimable functions in unbalanced models later.
2.6. An Alternative Perspective on the
ANOVA – Model Comparisons and R()
Notation
Before moving on to unbalanced designs, it is worth noting
that there are in fact two equally useful conceptualizations
of hypothesis tests in ANOVA models. Beyond understanding
hypothesis testing in terms of the construction of a sum of
squares Q, an alternative approach is via the concept of model
comparison. Here the sums of squares for a hypothesis is seen as
the difference in the sum of squared residuals for two competing
models. In this approach, the sums of squares for a particular
model term is seen as the reduction in error gained by the
inclusion of that term in the model. Such an understanding then
has an intuitive appeal, as the sums of squares can be seen as
quantifying the degree of improvement in the model fit when
additional terms are added.
A useful notation for indicating reductions in sums of squares
due to model comparisons is the R() notation described by Searle
(1987). Here a slightly simplified version of the R() notation is
used in the interests of clarity. As an example, the reduction in
the sum of squared errors found when fitting a model containing
µ and αi compared with a model containing only µ can be
expressed as
R(αi, . . . , αk|µ) = R(α|µ)
Terms to the right of | are consistent in bothmodels, and terms to
the left of | are only contained in one of the models. Alternatively,
this can be read as the effect of α after correcting for µ. When
considering these tests in relation to the reduction in the sum of
squared errors between two competing models, the R() notation
can be similarly interpreted as
R(α|µ) = SSE(µ)− SSE(µ,α)
where SSE() denotes the sum of squared errors for a model
containing the terms in brackets. An F-test can then be
understood as taking the form
F =
SSE(µ)− SSE(µ,α)
rσˆ 2
=
R(α|µ)
rσˆ 2
3. THE UNBALANCED
OVERPARAMETERIZED ANOVA MODEL
The theory behind ANOVA models is well described and
understood for balanced data. Unfortunately, greater complexity
is found when applying ANOVA models to data where the
number of observations per cell differ. For these so-called
unbalanced designs, much of the information provided from the
balanced case remains relevant. The difference in the unbalanced
case is that a clear decomposition of the total sums of squares
into the constituent effects of the model is no longer possible.
This is due to a loss of orthogonality between the ANOVA effects.
This can be demonstrated by considering that the decomposition
of sums of squares given in Equation (5) is only true in the
balanced case (Searle, 1987). When the data are not balanced, the
decompositions on the right hand side will not sum to the total
on the left hand side. This indicates that the partitions do not
constitute independent elements as the effects now overlap.
An example unbalanced dataset is given in Equation (8). A
demonstration of the decomposition of the sums of squares
for this dataset, and the preceding balanced dataset, is given
in Table 2. These sums of squares were obtained using the
decomposition in Equation (5). As it turns out, these sums of
squares are those associated with tests for each effect as if it
were the only effect in the model. For balanced data this is
not problematic as the tests are orthogonal. For unbalanced
data the lack of orthogonality means it is no longer sensible to
consider an effect in isolation given that its sums of squares are
no longer independent of the other terms. The only exception
to this is the interaction term which, as will be demonstrated,
never changes. It is therefore important to not blindly decompose
the total sum of squares as would be done in the balanced case.
Rather, the focus must be on sensible hypotheses, deriving the
appropriate sum of squares and the corresponding estimable
functions from there. Within the statistical literature there are
3 generally accepted approaches to deriving estimable functions
in unbalanced ANOVA models, known as the Type I–III sums
of squares. We note in passing that there is also a Type IV used
for data with empty cells, however, given that no neuroimaging
software accommodates empty cells we will not discuss them any
further.
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TABLE 2 | Example of the sums of squares derived from the traditional
decomposition of the total into the constituent effects for the balanced
and unbalanced data.
Sums of squares Balanced Unbalanced
Total 47.5 35.43
A 24.5 15.43
B 0.5 4.76
A × B 12.5 8.6
Error 10 9.5
A + B + (A × B) + Error 47.5 38.29
Only in the balanced case does the total also equal the sum of the decomposed elements.


7
4
3
2
5
8
8


=


1 1 0 1 0 1 0 0 0
1 1 0 1 0 1 0 0 0
1 1 0 0 1 0 1 0 0
1 1 0 0 1 0 1 0 0
1 0 1 1 0 0 0 1 0
1 0 1 1 0 0 0 1 0
1 0 1 0 1 0 0 0 1




µ
α1
α2
β1
β2
γ11
γ12
γ21
γ22


+


ǫ111
ǫ112
ǫ121
ǫ122
ǫ211
ǫ212
ǫ221


(8)
3.1. Type I Sums of Squares
Type I sums of squares, also known as sequential sums of squares,
are those associated with the testing of each effect of the model
in the order they are specified. In other words, this approach
provides tests where each effect is only adjusted for those that
precede it in the model equation. As such, the ordering of the
model is important. This can be most readily understood using
the R() notation detailed above, so that the Type I ANOVA table
for the model Yijk = µ + αi + βj + γij + ǫijk is as detailed in
Table 3.
For models with a natural ordering of terms, these tests can
provide useful results given that each term added to the model is
tested in relation to whether it provides greater predictive power
than those terms that are already present. For regression models
such tests are particularly useful, providing complimentary tests
to those on the individual coefficients. For neuroimaging, these
tests also provide the opportunity for a similar approach to
stepwise regression modeling, without the necessity of fitting
multiple models. However, it should be emphasized that better
model building strategies exist, such as the use of Akaike
Information Criterion (Akaike, 1998), and that the Type I tests
simply provide a workable approach within the confines of the
GLM testing procedures implemented in neuroimaging software.
In terms of the computation of the Type I tests, there are
two approaches consistent with either the model comparison or
estimable functions perspective. In relation to the interpretation
of these tests, their sums of squares can be readily computed
using the model comparisons detailed in Table 3. However, for
neuroimaging applications, where both models must be fit at
every voxel, this is a more demanding proposition. As such, it
is also possible to specify these tests using an estimable function
L. Though there are many ways to derive the weights of L, here
we present a generic procedure based on an LU factorization
TABLE 3 | The model comparisons that form the Type I sums of squares.
Effect Sum of squares
Constant R(µ)
A R(α|µ)
B R(β|µ,α)
A × B R(γ |µ,α,β)
of X′X using the Doolittle algorithm (Gaylor et al., 1970;
Goodnight, 1979). See the Supplementary Materials for example
MATLAB code implementing this approach for the purpose of
calculating contrast weights. As an example, the coefficients for
the unbalanced data presented above are given in Table 4.
Each row in Table 4 can be taken as an L matrix for testing
the model effects in the order they appear in X. For example,
the second row provides an L for testing the Type I main effect
of factor A, where the effect of the constant has been removed.
Similarly, the third row provides an L for testing the Type I
main effect of factor B, where the effect of both factor A and the
constant are removed. The final row contains the L for testing the
interaction term. Notably this has not changed from its familiar
form. If any effect spans more than 2 columns of X (such as
factor with > 2 levels) then there will be more than a single row
containing weights for the effect. In these cases, L will be a matrix
of weights consisting of the k−1 relevant rows from the Doolittle
factorization (where k is the number of levels of the factor).
Although somewhat less intuitive than model comparison,
the calculation of L allows a greater insight into the hypotheses
being tested by the Type I approach. Consideration of only
model comparison can lead one to conclude that such tests
need only be considered on the basis of whether a comparison
such as R(β|µ,α) is sensible in the context of the model.
Although true in part, the weights used to calculate an expression
such as R(β|µ,α) reveals one of the key disadvantages of this
approach for unbalanced data, as the hypotheses are dependent
on the cell frequencies. To see this, consider the L matrix
for R(α|µ) presented in the second row of Table 4. Using the
method detailed in Equations (6 and 7), this specification can be
simplified to a more intuitive form, as shown in Equation (9).
H0 :
1
2
µ11 +
1
2
µ12 −
2
3
µ21 −
1
3
µ22 = 0 (9)
Here it is clear that the weights associated with each cell mean
depend on the cell frequency. In this case, each weight is derived
from the number of subjects in the cell divided by the total
number of subjects at that level of factor A. Intuitively this
can be understood by considering that this L estimates a sum
of squares equivalent to comparing two models that contains
neither βj nor γij. To get such a test from a model that does
contain these terms, it is necessary to adjust the parameter
estimates. As will be shown later, the procedure to do so is
unavoidably dependent on the number of observations in each
cell. The classical objection to this approach is therefore that
the hypothesis can no longer be considered a testable statement
about population parameters, unless the frequency in the sample
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TABLE 4 | Type I contrast weights derived from Doolittle factorization of X′X in the example unbalanced dataset.
µ α1 α2 β1 β2 γ 11 γ 12 γ 21 γ 22
Constant 1 0.571 0.429 0.571 0.429 0.286 0.286 0.286 0.143
A 0 1 −1 −0.167 0.167 0.5 0.5 −0.667 −0.333
B 0 0 0 1 −1 0.6 −0.6 0.4 −0.4
A × B 0 0 0 0 0 1 −1 −1 1
is comparable to the frequency in the population (Searle, 1987).
Furthermore, given its dependence on the order of the model
terms, it is debatable how useful the hypothesis in Equation (9)
actually is for a traditional ANOVA model. Although these
insights appear damning of Type I tests, it is worth reiterating
that this approach is legitimate and useful in cases of ordered
regression models.
3.2. Type II Sums of Squares
Type II sums of squares are those associated with the testing
of model terms under the assumption that higher-order effects
containing those terms are zero. For example, when testing the
main effect of A the A× B interaction is assumed zero. Unlike the
Type I tests, however, the ordering of the model does not matter.
As such the main effect of A is adjusted for B, and the main effect
of B is adjusted for A. To make this clear, in a 3-way ANOVA
model with effects A, B, and C the Type II main effect of A would
be adjusted for B, C and B × C, but not A × B, A × C, or A ×
B × C as these effects contain A. This approach is shown from
the model comparison perspective in Table 5.
Like the Type I sums of squares, the model comparison
approach is relatively easy to implement via the model
comparisons depicted in Table 5. From the estimable function
perspective, Doolittle factorization of X′X can again be used,
recognizing that this would need to be conducted multiple times
with different Xs. In each case, the effect of interest is added
after terms for which it should be adjusted. If the model contains
continuous covariates care must be taken to place the covariates
before the factor of interest in X so that the sums of squares
are also adjusted for the covariates. As such, there can be a
large amount of model re-ordering in order to calculate the
Type II weights correctly. A more generic procedure that does
not require model re-ordering is detailed in the SAS algorithms
(https://support.sas.com/documentation/). As an example, the
Type II weights for the unbalanced data given earlier are shown
in Table 6.
Given the definition of the Type II tests, the only row that has
changed in Table 6 compared to Table 4 is the row associated
with factor A. The test coded in this row now produces a sum
of squares that is adjusted for the intercept and factor B. As with
before, the new hypothesis for factor A can be expressed in terms
of the cells means, as shown in Equation (10).
H0 :
3
5
µ11 +
2
5
µ12 −
3
5
µ21 −
2
5
µ22 = 0 (10)
In this form, one would be forgiven for thinking that the
hypothesis does not look intuitive, let alone useful. However, as
TABLE 5 | The model comparisons that form the Type II sums of squares.
Effect Sum of squares
Constant R(µ)
A R(α|µ,β)
B R(β|µ,α)
A × B R(γ |µ,α,β)
we will argue, framing a hypothesis test that reflects a model
without interaction terms within a model that does contain these
terms can be misleading. The hypothesis in Equation (10) is
actually identical to
H0 : α1 − α2 = 0 (11)
in the model Yijk = µ + αi + βj + ǫijk. From the model
comparison perspective, we are therefore comparing,
Yijk = µ+ βj + ǫijk
Yijk = µ+ αi + βj + ǫijk (12)
as indicated in Table 5. Despite the seemingly unintuitive nature
of this test when viewed from a cell means perspective, it is
clear from both Equations (11 and 12) that such a test is readily
understandable. As such, the slightly more involved arithmetic
necessitated by the cell means model should not distract from the
question that the test is posing. We shall return to this issue later.
3.2.1. The Principle of Marginality
Though we have now covered the interpretation and calculation
of the Type II tests, one may still wonder why such tests are of
any interest at all. This is particularly as, given the weights in
Table 6, similar caveats with the Type I approach exist as the
tests appear dependent on the cell frequencies. There is, however,
an appealing logic to these tests, known as the principle of
marginality (Nelder, 1977, 1994; Nelder and Lane, 1995). In brief,
this principle is based on the idea that interpreting a main effect
in the presence of an interaction is uninformative. Indeed, some
authors have gone as far as suggesting that any attempt to do so
is “...an exercise in fatuity” (Kempthorne, 1952). Based on this
logic, assuming that the interaction effect is zero is the only way to
produce a meaningful test of a main effect. As such, main effects
should only be adjusted for each other, as well as any interaction
that does not contain the main effect in question. If it turns
out that there is a significant interaction effect, the main effects
should be ignored as a matter of course. As such, the fact that
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TABLE 6 | Type II contrast weights derived from Doolittle factorization of X′X in the example unbalanced dataset.
µ α1 α2 β1 β2 γ 11 γ 12 γ 21 γ 22
Constant 1 0.571 0.429 0.571 0.429 0.286 0.286 0.286 0.143
A 0 1 −1 0 0 0.6 0.4 −0.6 −0.4
B 0 0 0 1 −1 0.6 −0.6 0.4 −0.4
A × B 0 0 0 0 0 1 −1 −1 1
In order to correctly calculate the weights for the main effect of factor A, the order of factor A and factor B must be swapped before performing the factorization of X′X.
the model comparison in Equation (12) assumes no interaction is
moot. As will be explained shortly, the Type III main effects tests
can be interpreted in terms of adjustments of main effects for all
other model terms. From the model comparison perspective, this
involves testing models containing interactions without all their
corresponding main effects. As such, the Type III tests implicitly
entertain models that are arguably unrealistic. It is for this reason
that the Type II tests are sometimes regarded more favorably
than the Type III (Nelder, 1977, 1994; Nelder and Lane, 1995;
Langsrud, 2003; Fox, 2008; Fox and Weisberg, 2011).
3.3. Type III Sums of Squares
Type III sums of squares are those associated with model
comparisons in sigma-restricted models where only single terms
are removed at a time. These are therefore tests where each
effect is adjusted for all other model terms, thus violating the
principle of marginality. Because of this, the model comparison
perspective on the Type III tests is where much of the controversy
surrounding the approach is found. However, the logic of the
tests from the perspective of hypotheses about cell means makes
the situation much clearer because these tests are the only ones
that do not depend on the cell frequencies. These tests are also
equivalent to Yates’ weighted square-of-means approach (Yates,
1934), are often used by default in statistical software packages
(e.g., SAS, SPSS, STATA), and correspond to the contrasts that
researchers are taught to use within the GLM in neuroimaging.
The Type III tests are shown in Table 7 from the model
comparison perspective. Here the notation from Searle (1987) is
adopted to indicate two key points about these tests. Firstly, as
stated above, the Type III tests based on model comparisons can
only be considered for models using sigma-restricted coding (see
the Supplementary Materials), a technicality discussed in Searle
(1987). It is this seemingly arbitrary aspect of the Type III tests
that has been used as an argument against their use (Venables,
1998), particularly given our earlier discussion of the fact that
the model constraints should not influence the answers gained
from the data. Here, both the Type I and Type II tests have
an advantage, as their values do not depend on the constraint
chosen for the model. Secondly, as indicated earlier, from the
model comparison perspective the Type III tests of main effects
involve comparing models with and without main effects, but
maintaining all interaction terms. In comparison to the Type II
approach, these tests do not treat the interaction effect as zero,
rather they average over them. In the balanced case these two
approaches are equivalent due to the orthogonality between the
main effect and interaction tests. For unbalanced data this is not
TABLE 7 | The model comparisons that form the Type III sums of squares.
Effect Sum of squares
Constant R(µ)
A R(α˙|µ, β˙, γ˙ )
B R(β˙|µ, α˙, γ˙ )
A × B R(γ˙ |µ, α˙, β˙)
The dot notation indicates that the parameters adhere to sigma-restrictions.
so. As an example, consider that the Type III main effect of factor
A involves the following model comparison,
Yijk = µ+ β˙j + γ˙ij + ǫijk
Yijk = µ+ α˙i + β˙j + γ˙ij + ǫijk
and thus implicitly entertains a model that contains an
interaction term with only one of the corresponding main effects.
As argued by a number of authors, it is debatable how sensible
this is (Venables, 1998; Langsrud, 2003; Fox, 2008; Fox and
Weisberg, 2011).
As with all the other approach discussed so far, an L matrix
can also be used the develop the Type III sums of squares. For the
Type III tests this is particularly advantageous, as this approach
is applicable to any coding of X. Again, the L weights can be
derived using Doolittle factorization of X′X, but only after X has
been reduced to its unique rows. This is therefore equivalent to
calculation of these effects in the balanced case. Here we see the
argument for using Type III tests emerging, as the Lmatrix used
for Type III tests does not depend on the cell frequencies. Using
this approach, the Type III weights for the example unbalanced
dataset are shown in Table 8.
Looking at the main effect of factor A, the Type III test
provides cell means comparison identical to Equation (6). As
such, the hypotheses on the cell means do not differ between
the balanced and unbalanced cases. As such the Type III tests
can be interpreted as testing hypotheses that are generalizable,
as they do not depend on the size of the sample. From this
perspective, it has been argued that these tests are therefore the
most appropriate for unbalanced data (Searle, 1987). However,
this is not necessarily reason enough to dismiss the fact that this
approach tests hypotheses that are arguably not sensible when
considered from amodel comparison perspective. Indeed, Nelder
(1977) insists that the forms of models that the Type III tests
actually compare are of “...no practical interest.” Such divergences
in opinion make it clear why the difference between the Type II
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TABLE 8 | Type III contrast weights derived from Doolittle factorization of X′X in the example unbalanced dataset.
µ α1 α2 β1 β2 γ 11 γ 12 γ 21 γ 22
Constant 1 0.5 0.5 0.5 0.5 0.25 0.25 0.25 0.25
A 0 1 −1 0 0 0.5 0.5 −0.5 −0.5
B 0 0 0 1 −1 0.5 −0.5 0.5 −0.5
A × B 0 0 0 0 0 1 −1 −1 1
Here the weights are derived after reduction of X to unique rows.
TABLE 9 | Demonstration of the differing approaches to producing
marginal means in the presence of interaction effects using either equally
weighted or frequency weighted cell means.
Approach Cell 1 Cell 2 Result
Averaged – ignoring cells 7 8,9 8
Equally weighted means (Type III) 12 × 7
1
2 × 8.5 7.75
Frequency weighted means (Type I–II) 13 × 7
2
3 × 8.5 8
and Type III sum of squares remains such a contentious topic.
This is particularly true given that the perspective one takes on
such tests can lead to equally valid arguments for and against
their use. As such, it is important to realize that none of the
tests are “wrong” per-se, rather they are simply asking different
questions.
3.4. Overview and Merits of the Type I–III
Tests
Now that the differences between the Type I–III tests has been
covered, we turn to more general debate on their individual
merits for hypothesis testing in classical ANOVA designs. Before
doing so, we first present a concrete example to help elucidate the
differences between how the means for the varying hypotheses
are calculated in the Type I–III cases. Given that it is in the
main effects tests that the various methods differ, it should be no
surprise that it is the calculation of the marginal means that holds
the key to understanding the different approaches.
3.4.1. Calculation of Marginal Means in the Type I–III
Tests
In Table 9 there are three data points from two hypothetical
cells of data containing different numbers of observations. In
row 1 we simply average all the data ignoring the cells, in row
2 we use equally weighted cell means, and in row 3 we use cell
means weighted by the cell frequency. When the two cells are
ignored, and the data are treated as coming from the same source,
the results differ from when the cell means are averaged over.
If instead the cell means are weighted by the cell frequency,
the original row mean can be recovered. Herein lies the key
conceptual differences between the Type III (equally weighted
means) and the Type I–II (cell frequency weighted means)
approaches. Here it is clear that the very process of correcting
the cell means to recover the original row mean necessitates the
use of the cell frequencies.
3.4.2. The Type II vs. Type III Debate
As covered earlier, the Type I tests have limited utility beyond
ordered regression models, where they should be considered
as complimentary to the standard t-tests on the coefficient
values. As such, much of the debate in the ANOVA literature
relates to the choice between the Type II and Type III tests.
Ultimately, much of this debate lies within ones feelings about
the purpose of hypothesis testing in statistical models. As
highlighted by Langsrud (2003) and Fox and Weisberg (2011),
the ultimate aim of hypothesis testing should be the desire to
answer specific and meaningful questions. Mathematically, this
is expressed using linear combinations of the model parameters,
however, inference on parameters without a foundation in
meaningful questions is arguably counter to the purpose of
statistical modeling. The reason that the Type II tests are often
argued against is that they are considered solely in relation to
parameters from models with interaction terms, rather than in
consideration of the questions they ask. Indeed, the Type II tests
of parameters from such models necessitate corrections in order
to render their values equivalent to a model without interaction
terms. This correction depends on the cell frequencies, but
ultimately guarantees that the same question is being posed
irrespective of the model form. As such, the question itself
should therefore be the point of debate for the merit of the
test, rather than the specific arithmetic details of how such
a question can be posed across different models of the same
data. From this perspective, the dependence on cell frequency
in Equation (10) should not be considered an indictment
about the worth of the hypothesis being tested, particularly
as such a question is poorly framed in a model containing
interaction terms. This ultimately highlights the limitations of
only considering the ANOVA tests as hypotheses about the
model parameters, particularly as this is arguably not the most
important perspective on hypothesis testing. Such arguments
weight heavily in favor of the the Type II tests over the Type
III tests. In addition, the Type II tests of main effects are often
more powerful than the Type III tests (Lewsey et al., 1997, 2001;
Langsrud, 2003), a point of particular note for neuroimaging.
As such, the Type II tests deserve serious consideration as the
default approach for hypothesis testing in unbalanced ANOVA
models. They are principled, sensible, and powerful tests that
ask meaningful questions. Unlike the Type III tests, they do not
depend on the model constraints when viewed from a model
comparison perspective, and similarly, they do not implicitly
entertain unrealistic models when testing main effects. When
seen from the perspective of the questions posed to the data, it
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is difficult to argue against the approach taken by the Type II
tests.
4. THE UNBALANCED
OVERPARAMETERIZED ANOVA MODEL IN
NEUROIMAGING SOFTWARE
Now that the different approaches to dealing with unbalanced
data in ANOVA models have been discussed, we turn to
the practical application of these approaches in neuroimaging
software. In this section we present the construction of the Type
I–III tests in two of the most popular neuroimaging analysis
software packages: SPM (www.fil.ion.ucl.ac.uk/spm/) and FSL
(fsl.fmrib.ox.ac.uk/fsl/). Though we have limited examples to just
these two packages, any analysis software that implements the
mass-univariate GLM could be used. In all examples the model
is a 2 × 2 between-subject ANOVA with cell counts as given in
Table 10.
4.1. SPM
4.1.1. Using the Flexible Factorial Module
Using an overparameterized design in SPM necessitates the
use of the Flexible Factorial module. The SPM design
matrix for the overparameterized ANOVA model is shown in
Figure 1. Here a constant column has been added by specifying a
covariate vector of ones. It is notable here that SPM has indicated
that none of the parameters from this model will be unique,
by providing a gray box per column below the design matrix.
This is in keeping with the point made earlier about differing
solutions in overparameterized designs, essentially highlighting
that the values of the individual beta_*.nii images cannot be
meaningfully interpreted. Once specified, this matrix is available
in the SPM.mat file as X = SPM.xX.X, for the unfiltered
design matrix. This is a convenience, as it is not necessary
to specify the design matrix manually for use in a Doolittle
factorization. It is, however, necessary to move the intercept
column from last to first (e.g., X = [X(:,size(X,2))
X(:,1:size(X,2)-1)]).
Using the Doolittle factorization of X′X provides scaled
versions of the Type I weights for L. Using theMATLAB function
given in the Supplementary Materials, this could be specified
very simply as W = doolittleWeights(X). An example of
specifying these effects in SPM is given in Figure 2A. Note that
each of the contrasts were specified on a single line, but have been
wrapped within the input box.
TABLE 10 | Group numbers for the example unbalanced neuroimaging
data.
A A Total B
1 2
B 1 13 14 27
B 2 13 15 28
Total A 26 29 55
Derivation of the Type II tests follows much the same
procedure. In this case the Doolittle factorization is performed
twice, swapping the ordering of factor A and factor B inX. In this
instance, the weights provided by the second decomposition are
simply re-arranged so that they align with the original ordering
of X. These weights are shown specified in the SPM contrast
manager in Figure 2B. As expected, the L matrices for the
interaction and main effect of B are identical to those in the Type
I case.
As an additional point, it may be advantageous to make use of
the contrast masking facility in SPMwhen exploring Type II main
effects. Such an approach allows one to effectively “censor” voxels
where a high-order effect is significant. As such, investigations of
Type II main effects can be made only in voxels where the higher-
order effects are suitably null. If there are multiple higher-order
effects, a mask image of all significant higher-order effects could
be used.
The Type III tests are those that will seem the most familiar
to neuroimaging researchers. Their derivation from a Doolittle
factorization is performed after reducing X to its unique rows.
Again, using the MATLAB function given in the Supplementary
Materials, this can be specified on a single line as W
= doolittleWeights(unique(X, ‘rows’)). Because
the Type III tests do not depend on cell frequency, they will
FIGURE 1 | The design matrix visualization for an overparameterized
ANOVA model in SPM. The use of an overparameterized ANOVA design is
possible using the SPM Flexible Factorial module. Here, the blocks
below the design matrix are gray, indicating that unique values for the
parameters do not exist. The constant is placed on the end of the design as it
is not included by default, rather it is added by specifying a covariate of ones.
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FIGURE 2 | The Type I–III hypotheses specified in the SPM contrast manager. (A) Type I ANOVA weights (B) Type II ANOVA weights (C) Type III ANOVA
weights. The green text below the input box for each example indicates that each contrast is an estimable function, as it has passed the estimability test used by SPM.
be the same no matter the number of observations. These tests
can therefore be constructed more generically using the number
of cells rather than the frequencies within the cells. Generally
speaking, this is much easier to do, and likely contributes to
why the Type III contrast weights are generally taught for use
in neuroimaging software. These tests are shown in the SPM
contrast manager in Figure 2C.
4.1.2. Using Other SPM Modules
Although the above example made use of overparameterized
designs in the SPM Flexible Factorial module, it is
perfectly possible to derived the tests using any of the other
models available in SPM. For example, if it is desirable to
instead use the SPM Full Factorial module to specify a
cell means design, then the contrasts already derived can easily
be adjusted. The method used to convert an overparameterized
contrast to a cell means contrast has already been demonstrated
in Equations (6 and 7). However, for the current tests, it is more
straightforward to simply take the weights associated with the
interaction term and apply them to the cell means model. This
is demonstrated for the Type II tests in Figure 3.
4.2. FSL
As mentioned earlier, FSL does not allow overparameterized
designs to be used. This means that the overparameterized
ANOVA model cannot be specified in FEAT directly. However,
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FIGURE 3 | Specification of the Type II tests for a cell means ANOVA in SPM. The weights given in the contrast manager were derived from the
overparameterized models given earlier. Although a more principled approach can be used to discern these weights, as shown in Equations (6 and 7), in this instance
the weights were simply taken from the interaction terms in Figure 2B.
FIGURE 4 | The Type I–III hypotheses specified in FSL FEAT. The models shown here include (A) treatment coding and (B) sigma restricted coding. These are
both legitimate alternatives to the cell means model, used to render X′X invertible. The cell means model is not shown as it is identical to SPM, with weights calculated
as indicated earlier.
it is possible to start with an overparameterized model, calculate
the estimable functions available to test the hypotheses of
interest, and then convert these functions into ones useable in
a model where X′X is invertible. Alternatively, both treatment
and sigma-restricted design matrices can be submitted to
Doolittle factorization to get the appropriate weights. The design
matrix from an FSL FEAT group-level model is stored as a
design.mat file in the corresponding *.gfeat directory.
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This is a text file written in the FSL VEST format, and could
be read into MATLAB using e.g., the palm_vestread()
function from the Permutation Analysis of Linear Models
(PALM) toolbox (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/PALM).
The function in the Supplementary Materials could then be used
to compute the Doolittle factorization of X′X, for example W =
doolittleWeights(palm_vestread(‘./example.
gfeat/design.mat’)). The appropriate weights from W
can then be entered back into FEAT.
The Type I-III tests are shown in the design visualization
from FEAT in Figure 4. Given that the Type III tests from
a sigma-restricted model are so straightforward, it is perhaps
not surprising that this approach is recommended on the FSL
GLMwiki (fsl.fmrib.ox.ac.uk/fsl/fslwiki/GLM). As the cell means
model is identical to SPM, this has been omitted. In addition,
contrast masking is also available in FEAT, and a such our
comments on the Type II tests in SPM remain relevant for FSL
also.
5. SUMMARY
In this paper we have given an overview of the use of estimable
functions in the GLM, paying particular attention to the different
forms of hypothesis tests available for unbalanced ANOVA
models. Though this issue has a long history in statistics, it has
seemingly not been considered in the neuroimaging literature.
Despite the fact that Type III tests have been settled on exclusively
in popular software packages, there may be merit in the Type I
and II tests for certain designs and approaches. Indeed, the Type
II tests in particular provide greater power for investigating main
effects, and arguably provide a more sensible hypothesis testing
framework via the principle of marginality. Understanding the
difference between these tests, and their derivation, allows for
greater flexibility in the use of the GLM in neuroimaging,
particularly in unbalanced designs. We have also touched on the
use of Type I tests in regressions models, suggesting that these
forms of hypotheses could be useful in ordered designs where
the test of each coefficient is only adjusted for those that precede
it. Using the overparameterized ANOVA model as a base, we
have shown how all these tests can be derived from a generic
framework that can be adjusted to suit any form of coding used.
Such an approach allows immediate application irrespective of
the software package used, but also provides a key focus on
hypothesis testing as the single most important aspect of using
the GLM with neuroimaging data.
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